Proteus Digital Health Stock

proteus.comHealthcare / BioTech & PharmaFounded: 2001Funding to Date: $397.36MM

Proteus Digital Health is a biotechnology company focused on creating a new category of pharmaceuticals: Digital Medicines, which include drugs that communicate when they’ve been taken, wearable sensors that capture physiologic response, applications that support patient self-care and physician decision making, and data analytics to serve the needs of doctors and health systems.

Register To Buy and Sell Shares

For more details on financing and valuation for Proteus Digital Health, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

OverviewFinancingsValuation

Enterprise Value

Powered by Forge Data

Access Proteus Digital Health’s valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Proteus Digital Health.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.

Register

Animation displayed is not current and securities are shown for illustrative purposes only.

Proteus Digital Health investors also invested in these private companies

Team

Management Team

Andrew Thompson
Co-Founder
George Savage, M.D.
Co-Founder, Chief Medical Officer
Mark Zdeblick, Ph.D.
Co-Founder

Board Members

Shumeet Banerji, Ph.D.
Frank Fischer
Immanuel Thangaraj
Regina Benjamin, MD, MBA
Alan J. Levy, Ph.D.
Joseph R. Swedish
Andrew Thompson
Sir Jonathan Symonds, CBE
Robert Epstein, M.D., M.S.
Ryan Schwarz

News Highlights

The Instant, Custom, Connected Future of Medical Devices
3D-printed and “smart” pharmaceuticals are making medical treatments more effective. But it may take years before the new devices reach most patients, if they do at all.
Drug Adherence Enhancement Market: Devices and Applications, 2018-2030
NEW YORK, Feb. 6, 2019 /PRNewswire/ -- INTRODUCTION Poor adherence to prescribed medications is a growing concern in the healthcare industry and is believed to ...
スタッキング可能 スツール M-22
スタッキング可能 スツール M-22
Updated on: May 25, 2024

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.